APVO earnings
Aptevo Therapeutics (APVO) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
- APVO beat EPS estimates in 5 of its last 13 reports.
APVO earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q3 2026 | Nov 16, 2026 | -5.19 | -3.71 | -39.89% | – |
| Q2 2026 | Aug 14, 2026 | -5.31 | -6.01 | 11.65% | – |
| Q1 2026 | May 13, 2026 | -6.41 | -5.60 | -14.46% | – |
| Q4 2025 | Feb 13, 2026 | -6.28 | – | – | – |
| Q3 2025 | Nov 6, 2025 | -40.11 | -37.59 | -6.70% | – |
| Q2 2025 | Aug 11, 2025 | -151.20 | -83.20 | -81.73% | – |
| Q1 2025 | May 15, 2025 | -1579.14 | -4.21 | -37409.26% | – |
| Q3 2024 | Nov 7, 2024 | -6255.86 | -7428.84 | 15.79% | – |
| Q2 2024 | Aug 8, 2024 | -21765.20 | -25153.79 | 13.47% | – |
| Q1 2024 | May 8, 2024 | -129678.87 | -183766.03 | 29.43% | – |
| Q3 2023 | Nov 14, 2023 | -287071.63 | -0.75 | -38276117.33% | – |
| Q2 2023 | Aug 10, 2023 | -706196.19 | -1.12 | -63053131.25% | – |
| Q1 2023 | May 11, 2023 | 149277.23 | -1.19 | 12544405.04% | – |
| Q3 2022 | Nov 10, 2022 | -67.43 | -1.64 | -4011.35% | $0.00 |